Download Investor Presentation & Receive Updates

Willow Bioscience (CSE:WLLW) is a synthetic biology company focused on producing pharmaceutical grade cannabinoids via industrial scale biosynthesis.

Willow has a world class team of academic and industrial scientists with a long history in medicinal plants who most recent program involved creating and scaling up a yeast strain to produce thebaine via biosynthesis.


Enzyme Research

Groundbreaking discoveries in biosynthesis.

Low Cost Production

World Class Team

Fully Funded

Synthetic cannabinoids are much cheaper to produce than plant based.

$29M in funding secured.

Academic and industrial scientists with a long history in medicinal plants.

Copyright © 2018 All Rights Reserved.

Sign Up to Learn More About Willow Biosciences.